Advertising and Promotion Regulatory Affairs Conference

Mergers and acquisitions are commonly complex and high value activities with long-term significance. To understand and appreciate the full range of obligations, liabilities, risks and opportunities in an M&A transaction, important information relating to the commercial, financial, legal, regulatory, and administrative, the status of the assets and parties must be evaluated in a thorough and robust due diligence investigation. This session will discuss due diligence best practices for life sciences companies and provide valuable insights and strategies for cross-functional due diligence teams, with particular emphasis on the regulatory and compliance standards of the target asset or company.